Smoking should be treated as a form of drug addiction, with smoking
cessation services and interventions such as nicotine replacement
therapy available to all smokers on the NHS, according to a report
published by the Tobacco Advisory Group of the Royal College of
Physicians.
The report calls for a major shift in attitude towards smoking.
Doctors, other health professionals, and society "need to acknowledge
nicotine addiction as a major medical and social problem" akin to
addiction to certain hard drugs, such as cocaine and heroin.
Most smokers do not smoke out of choice, claims the report, but
because they are addicted to nicotine. "We would like to see health
professionals and the public accept smoking as a disorder that needs
to be treated just like any other disease," commented Professor
John Britton, chairman of the report and professor of respiratory
medicine at the University of Nottingham. "At the moment smoking
is seen as an optional activity."
Help to overcome nicotine addiction should be provided on the NHS
in the same way as services to treat alcoholism and drug addiction.
Nicotine replacement therapy is as cost effective as most other
medical interventions, costing between £212 ($339) and £873 per
year of life saved (1996 prices), claims the report.
It also calls for further research into the use and safety of nicotine
replacement therapy in pregnant women, a third of whom continue
to smoke.
Nicotine replacement therapy and other interventions, such as the
antidepressant bupropion, which should be available in the United
Kingdom later this year, double the quitting rate. Combining these
methods with behavioural support such as group counselling can boost
cessation rates to as much as 35% at one year.
Even though these effects seem small, providing these interventions
widely on the NHS would "yield substantial returns in terms of the
numbers of people who give up smoking," states the report, because
smoking is so common.
In 1997 a quarter of adults were regular smokers. Although smoking
has been declining over the past 50 years, it seems to have stabilised.
By the age of 15, a quarter of children smoke, and about 50% of
young adult smokers will still be smoking when they are 60.
Even switching to low yield cigarettes may be counter-productive.
In fact, people who opt for these brands compensate by smoking more
deeply with very little, if any, reduction in the amount of nicotine
and tar they inhale and little health benefit.
Smoking is the single most important public health problem in Britain
and costs the NHS an estimated £1.5bn each year.
Professor Britton would like the Department of Health to recognise
the problem of nicotine addiction and to lift the prescription restrictions
currently applied to nicotine replacement products or to make them
available over the counter at a reasonable price.
"It is totally unreasonable to provide expensive treatments such
as statins on the NHS and yet to ban a more cost effective treatment
that gives many more years of life," he said. In addition, cigarettes
should be required to meet the same safety standards as other nicotine
delivery products, such as nicotine replacement therapy, as set
by the Medicines Control Agency.